Abstract
The emergence of resistant phenotypes following the introduction of new antibiotics is well documented. However, the subsequent dynamics of resistance frequencies over long time periods are less well understood: the extent to which resistance frequencies increase, the rate at which resistance frequencies change, and how this depends on antibiotic consumption remain open questions. Here, we systematically analyse the resistance trajectories emerging from 3,375,774 hospital bacterial isolates sampled from infections in Europe over 1998-2019, representing 887 bug-drug-country combinations. Our analyses support a model in which, after an initial increase, resistance frequencies reach a stable intermediate equilibrium. The plurality (37%) of analysed trajectories were best described as ‘stable’ (neither increasing nor decreasing). The second largest category of trajectories (21%) was those best described as ‘stabilising’ – i.e. showing a transition from increasing frequency to a stable plateau. The antibiotic consumption in a country predicts both the equilibrium frequency of the corresponding resistance and the speed at which this equilibrium is reached. Moreover, we find weak evidence that temporal fluctuations in resistance frequency are driven by temporal fluctuations in hospital antibiotic consumption. Overall, our results indicate that ever increasing antibiotic resistance frequencies are not inevitable and that antibiotic management limits resistance spread. A large fraction of the variability in the speed of increase and the equilibrium level of resistance remains unexplained by antibiotic use, suggesting other factors also drive resistance dynamics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
FB is funded by ERC StG 949208 EvoComBac. SL is funded by the Swiss National Science Foundation (PR00P3\_201618).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* joint last authors
Data Availability
The data is available upon request from the European Centre for Disease Prevention and Control (ECDC). All code is available on the following GitHub repository: https://github.com/mjemons/temporal-trends-AMR-manuscript
